Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,429,410 | 2,158,688 | 1,400,849 | 1,425,059 | 1,112,232 |
| Marketable Securities | 1,630,235 | 1,926,514 | 1,760,230 | 1,651,617 | 1,351,071 |
| Receivables | 970,195 | 718,304 | 857,105 | 540,622 | 415,478 |
| Inventories | 8,990 | 8,276 | N/A | N/A | N/A |
| Other current assets | 0 | 0 | -1 | 0 | 0 |
| TOTAL | $4,038,830 | $4,811,783 | $4,018,183 | $3,617,298 | $2,878,781 |
| Non-Current Assets | |||||
| PPE Net | 141,810 | 138,666 | 113,138 | 98,801 | 69,400 |
| Investments And Advances | 33,060 | 19,457 | 18,833 | 59,026 | 165,609 |
| Intangibles | 2,157,310 | 14,665 | 20,674 | 40,411 | 51,782 |
| Other Non-Current Assets | 271,585 | 139,392 | 116,537 | 102,620 | 73,536 |
| TOTAL | $2,603,765 | $312,180 | $269,182 | $300,858 | $360,326 |
| Total Assets | $6,642,595 | $5,123,963 | $4,287,365 | $3,918,156 | $3,239,108 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 504,890 | 334,976 | 242,986 | 235,468 | 181,542 |
| Other current liabilities | 3,480 | N/A | N/A | N/A | N/A |
| TOTAL | $769,660 | $360,677 | $258,137 | $249,469 | $191,960 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 4,792 | 4,673 | 4,137 | 3,983 |
| Other Non-Current Liabilities | 209,815 | 103,818 | 75,614 | 59,822 | 43,202 |
| TOTAL | $551,870 | $173,514 | $143,582 | $137,303 | $117,811 |
| Total Liabilities | $1,321,530 | $534,191 | $401,719 | $386,772 | $309,770 |
| Shareholders' Equity | |||||
| Common Shares | 9,570 | 9,583 | 9,346 | 10,501 | 10,111 |
| Retained earnings | 3,414,895 | 2,762,140 | 2,119,469 | 1,594,182 | 1,088,792 |
| Other shareholders' equity | 71,050 | 8,712 | 13,877 | 12,887 | 8,273 |
| TOTAL | $5,321,065 | $4,589,772 | $3,885,646 | $3,531,384 | $2,929,337 |
| Total Liabilities And Equity | $6,642,595 | $5,123,963 | $4,287,365 | $3,918,156 | $3,239,107 |